SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (2111)1/17/2008 10:19:13 AM
From: Jibacoa  Read Replies (3) | Respond to of 3722
 
In spite of its lower revenues & higher losses, ITMN wants to test its resistance at the $20 level.<g>

bigcharts.marketwatch.com

Terence Flynn, an "analyst" at Lazard Capital Markets has a "Buy" rating and $30 price target for ITMN.He said it will likely successfully develop a BID schedule for ITMN-191.(ITMN has been working on both a BID & TID dosing.)

ITMN is almost getting off the DT coming from its Feb H at $36.60. I think I would wait for it to get over the $20 resistance & keep a "target" at $25, while also waiting for the 4thQ results, since the EL for 2007 is around $2.62 vs. $1.99 in 2006 <g>

bigcharts.marketwatch.com

Bernard